Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Chembio Diagnostics Inc. market cap is $16.73M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Chembio Diagnostics Inc. 52 week high is $1.24 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Chembio Diagnostics Inc. 52 week low is $0.19 as of November 22, 2026.
Chembio Diagnostics Inc. stock price today is $0.455.
Chembio Diagnostics Inc. stock price yesterday was $0.454.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Chembio Diagnostics Inc.'s P/E ratio is -0.6.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Chembio Diagnostics Inc. P/B ratio is 0.9399.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Chembio Diagnostics Inc. 50-day moving average is $0.4306.